Literature DB >> 16511646

Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.

Stefan J Teipel1, Jens C Pruessner, Frank Faltraco, Christine Born, Manoela Rocha-Unold, Alan Evans, Hans-Jürgen Möller, Harald Hampel.   

Abstract

BACKGROUND: Early pathological involvement of specific medial temporal lobe areas is characteristic for Alzheimer's disease (AD).
OBJECTIVE: To determine the extent of regional medial temporal lobe atrophy, including hippocampus, amygdala, and entorhinal, perirhinal, and parahippocampal cortices in mild AD patients and healthy controls, and to compare diagnostic accuracy across volumetric markers.
METHODS: We studied 34 patients with clinically probable AD and 22 healthy elderly control subjects. Regional volumetric measures were obtained from volumetric T1-weighted MRI scans after accounting for global brain atrophy using affine transformation into standard space.
RESULTS: Volumes of medial temporal lobe structures were significantly smaller in AD patients than in controls with exception of the left entorhinal cortex. The degree of atrophy was comparable between all structures. Diagnostic accuracy (number of correctly allocated cases divided by number of all cases) was highest for the right parahippocampal cortex with 85%, but only slightly lower for the right hippocampus and right entorhinal cortex with 82% and 84%. Using a linear combination of markers, the unilateral volumes of the right hippocampus, parahippocampal cortex and perirhinal cortex yielded an accuracy of 93%.
CONCLUSION: Extent of atrophy is similar between the different regions of the medial temporal lobe in mild AD.Volume measurements of medial temporal lobe structures in addition to the hippocampus only yield improved diagnostic accuracy if a combination of these structures is used.

Entities:  

Mesh:

Year:  2006        PMID: 16511646     DOI: 10.1007/s00415-006-0120-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  MRI of entorhinal cortex in mild Alzheimer's disease.

Authors:  M Bobinski; M J de Leon; A Convit; S De Santi; J Wegiel; C Y Tarshish; L A Saint Louis; H M Wisniewski
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

2.  Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD.

Authors:  D J Callen; S E Black; F Gao; C B Caldwell; J P Szalai
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

3.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

4.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

5.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

6.  Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study.

Authors:  M P Laakso; G B Frisoni; M Könönen; M Mikkonen; A Beltramello; C Geroldi; A Bianchetti; M Trabucchi; H Soininen; H J Aronen
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

7.  Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.

Authors:  Gaël Chetelat; Jean-Claude Baron
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

9.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.

Authors:  Corina Pennanen; Miia Kivipelto; Susanna Tuomainen; Päivi Hartikainen; Tuomo Hänninen; Mikko P Laakso; Merja Hallikainen; Matti Vanhanen; Aulikki Nissinen; Eeva-Liisa Helkala; Pauli Vainio; Ritva Vanninen; Kaarina Partanen; Hilkka Soininen
Journal:  Neurobiol Aging       Date:  2004-03       Impact factor: 4.673

10.  Altered glucose metabolism in the hippocampal head in memory impairment.

Authors:  Y Ouchi; S Nobezawa; H Okada; E Yoshikawa; M Futatsubashi; M Kaneko
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

View more
  31 in total

1.  Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Klaus H Fritzsche; Bram Stieltjes; Sarah Schlindwein; Thomas van Bruggen; Marco Essig; Hans-Peter Meinzer
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-04       Impact factor: 2.924

2.  Sub-millimeter isotropic MRI for segmentation of subcortical brain regions and brain visualization.

Authors:  Ying Wu; Ann B Ragin; Hongyan Du; Shawn Sidharthan; Eugene E Dunkle; Ioannis Koktzoglou; Robert R Edelman
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

3.  Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction.

Authors:  R Scott Mackin; J Craig Nelson; Kevin L Delucchi; Patrick J Raue; Derek D Satre; Dimitris N Kiosses; George S Alexopoulos; Patricia A Arean
Journal:  Am J Geriatr Psychiatry       Date:  2014-02-26       Impact factor: 4.105

4.  Neuroimaging of individuals with Down's syndrome at-risk for dementia: evidence for possible compensatory events.

Authors:  R J Haier; K Head; E Head; I T Lott
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

5.  Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy.

Authors:  Yue-Ming Jiang; Li-Ling Long; Xia-Yan Zhu; Hong Zheng; Xue Fu; Shi-Yan Ou; Dong-Lu Wei; Hai-Lin Zhou; Wei Zheng
Journal:  Toxicol Lett       Date:  2008-07-23       Impact factor: 4.372

Review 6.  Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.

Authors:  A Del Sole; S Malaspina; Alberto Magenta Biasina
Journal:  Funct Neurol       Date:  2016 Oct/Dec

7.  Regionally selective atrophy after traumatic axonal injury.

Authors:  Matthew A Warner; Teddy S Youn; Tommy Davis; Alvin Chandra; Carlos Marquez de la Plata; Carol Moore; Caryn Harper; Christopher J Madden; Jeffrey Spence; Roderick McColl; Michael Devous; Richard D King; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2010-07-12

8.  Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Authors:  Lei Cao; Hui-Fu Wang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-03-22

Review 9.  Novel MRI techniques in the assessment of dementia.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Helmut Heinsen; Harald Hampel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

Review 10.  Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Authors:  Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Mark W Jacobson; Anders M Dale
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.